Latest Form 4 insider transactions

NASDAQ
Mann Lindsay Drucker, Global Chief Financial Officer of Oddity Tech Ltd, reported multiple transactions in common stock on July 31, 2026.
NASDAQ
Brian T Hamilton, President of CCBX and a Director of Coastal Financial Corp, reported a transaction in 226 shares of common stock on August 3, 2026.
NYSE
Henry M. Hoffman, a Director of Skillz Inc., reported multiple transactions in common stock on August 3, 2026.
NYSE
Kent Wakeford, a Director of Skillz Inc., reported multiple transactions in common stock on July 31, 2026.
NASDAQ
Michelle Gilson, a Director of Rani Therapeutics Holdings, Inc., received 247,200 shares of common stock on August 3, 2026.
Space Summit Capital LLC and 1 other reported changes in beneficial ownership of East West Ave Acquisition Corp. common stock on July 31, 2026.
NASDAQ
Claire Weston, a Director of Gyre Therapeutics, Inc., received 40,000 shares of common stock on August 3, 2026.
NYSE
Andrew H Everett Ii, Sr. VP, General Counsel & Secy of SEACOR Marine Holdings Inc., sold 6,131 shares of common stock on August 3, 2026.
Peter O'Rourke, a Director of Mainz Biomed N.V., received 190,840 shares of common stock on July 31, 2026.
David Natan, a Director of Mainz Biomed N.V., received 190,840 shares of common stock on July 31, 2026.
William J Caragol, Chief Financial Officer of Mainz Biomed N.V., received 212,500 shares of common stock on July 31, 2026.
NASDAQ
Maxwell Kirkby, a Director of Gyre Therapeutics, Inc., received 40,000 shares of common stock on August 3, 2026.
NASDAQ
James Woodruff Lillie, Chief Scientific Officer of MapLight Therapeutics, Inc., sold 22,082 shares of common stock on August 3, 2026 for $12.54 per share.
Louis R. Buffalino, a Director of Mainz Biomed N.V., received 425,000 shares of common stock on July 31, 2026.
NASDAQ
Pramod Badjate, President & GM, NFB of Netgear, Inc., sold 3,000 shares of common stock on July 31, 2026.
NASDAQ
Kathleen B Kay, a Director of Seacoast Banking Corp Of Florida, received 2,015 shares of common stock on July 31, 2026.
NASDAQ
Charles J. Prober, Chief Executive Officer and a Director of Netgear, Inc., reported a transaction in 4,598 shares of common stock on July 31, 2026.
NASDAQ
Bryan Murray, Chief Financial Officer of Netgear, Inc., reported multiple transactions in common stock on July 31, 2026.
NYSE
REH Advisors Inc. reported changes in beneficial ownership of HF Sinclair Corp common stock on August 2, 2026.
NASDAQ
Bryan Murray, Chief Financial Officer of Netgear, Inc., received 9,461 shares of common stock on January 27, 2026.
NASDAQ
Shimon Steinmetz, Chief Financial Officer of Arq, Inc., reported multiple transactions in common stock on July 31, 2026.
NASDAQ
Claiborne Benson Smith, Gen Counsel, Corp Secretary of Arq, Inc., reported multiple transactions in common stock on August 1, 2026.
NASDAQ
George Kurtz, PRESIDENT AND CEO and a Director of CrowdStrike Holdings, Inc., sold 37,525 shares of common stock on August 3, 2026.
NASDAQ
Burt W. Podbere, CHIEF FINANCIAL OFFICER of CrowdStrike Holdings, Inc., sold 7,622 shares of common stock on August 3, 2026.
NASDAQ
Joseph M Wong, Chief Technology Officer of Arq, Inc., reported multiple transactions in common stock on August 1, 2026.
NYSE
Melissa Mann, Chief People Officer of Inspire Medical Systems, Inc., reported multiple transactions in common stock on July 31, 2025.
NASDAQ
Yong Yu, Chief Scientific Officer of GENELUX Corp, sold 653 shares of common stock on August 4, 2026 for $2.94 per share.
NASDAQ
Joseph Cappello, Chief Technical Officer of GENELUX Corp, sold 653 shares of common stock on August 4, 2026 for $2.95 per share.
NASDAQ
Thomas Zindrick, President and CEO of GENELUX Corp, sold 3,023 shares of common stock on August 4, 2026 for $2.95 per share.
NASDAQ
Bernard Shek, Chief Legal Officer & Secty of Sandisk Corp, sold 600 shares of common stock on August 3, 2026 for $1,162.16 per share.